Compare KNTK & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KNTK | WVE |
|---|---|---|
| Founded | 2017 | 2012 |
| Country | United States | Singapore |
| Employees | N/A | N/A |
| Industry | Natural Gas Distribution | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.4B |
| IPO Year | 2017 | 2015 |
| Metric | KNTK | WVE |
|---|---|---|
| Price | $47.10 | $13.89 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 15 |
| Target Price | ★ $45.18 | $30.73 |
| AVG Volume (30 Days) | 1.7M | ★ 2.4M |
| Earning Date | 05-29-2026 | 05-29-2026 |
| Dividend Yield | ★ 7.12% | N/A |
| EPS Growth | ★ 157.84 | N/A |
| EPS | ★ 2.63 | N/A |
| Revenue | ★ $160,617,000.00 | $3,704,000.00 |
| Revenue This Year | $14.83 | $16.76 |
| Revenue Next Year | $18.61 | $149.85 |
| P/E Ratio | $17.26 | ★ N/A |
| Revenue Growth | 8.23 | ★ 149.43 |
| 52 Week Low | $31.33 | $5.28 |
| 52 Week High | $55.96 | $21.73 |
| Indicator | KNTK | WVE |
|---|---|---|
| Relative Strength Index (RSI) | 67.28 | 51.31 |
| Support Level | $42.85 | $12.53 |
| Resistance Level | N/A | $14.56 |
| Average True Range (ATR) | 2.00 | 0.77 |
| MACD | 0.25 | 0.15 |
| Stochastic Oscillator | 86.23 | 45.78 |
Kinetik Holdings Inc is a midstream operator that provides gathering and processing services to gas and oil producers as well as pipeline transportation. In addition to directly operating pipelines, Kinetik also holds ownership stakes in several pipelines. The company operates in two reportable segments which include The Midstream Logistics segment operates under three service offerings, 1) gas gathering and processing, 2) crude oil gathering, stabilization, and storage services, and 3) produced water gathering and disposal. The Pipeline Transportation segment consists of three EMI pipelines originating in the Permian Basin with various access points to the U.S. Gulf Coast, Kinetik NGL Pipelines, and Delaware Link Pipeline.
WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.